Copyright © 2025 KAP
Central Securities Depository & Trade Repository of Türkiye
| ||||||||||||||||||||||
General Assembly Invitation | ||||||||||||||||||||||
| ||||||||||||||||||||||
Agenda Items | ||||||||||||||||||||||
1 - Discussion and decision regarding the opening of the meeting and the appointment of the Chair | ||||||||||||||||||||||
2 - Reading and discussion of the Board of Directors' Activity Report for the 2025 financial year | ||||||||||||||||||||||
3 - Reading and discussion of the Independent Audit Report for the 2025 financial year | ||||||||||||||||||||||
4 - Reading, discussion and submission for approval of the Company's financial statements for the 2025 financial year | ||||||||||||||||||||||
5 - Discussion and approval of the TSRS-compliant Sustainability Reports for the years 2024 and 2025 | ||||||||||||||||||||||
6 - The discussion and submission for approval of the Board of Directors' proposal regarding the distribution of profits for the 2025 financial year | ||||||||||||||||||||||
7 - Discussion and resolution regarding the discharge of Board Members from liability for their activities during the 2025 financial year | ||||||||||||||||||||||
8 - Providing information to Shareholders regarding the "Remuneration Policy" for Board Members and Senior Executives in accordance with the Corporate Governance Principles, and payments made under this policy | ||||||||||||||||||||||
9 - Determination of the remuneration of Board Members and Independent Board Members | ||||||||||||||||||||||
10 - To discuss and decide on granting authorisation to Board Members to carry out the transactions specified in Articles 395 and 396 of the Turkish Commercial Code | ||||||||||||||||||||||
11 - Discussion and decision-making regarding the selection of the Independent Audit Firm for the 2026 financial year in accordance with the Turkish Commercial Code and Capital Markets Board regulations | ||||||||||||||||||||||
12 - Discussion and decision-making regarding the approval of the Independent Audit Firm proposed by the Board of Directors for the purpose of conducting the assurance audit of the Company's sustainability report for the 2026 financial year and carrying out other activities within the framework of relevant regulations | ||||||||||||||||||||||
13 - To provide the General Meeting with information regarding the donations and contributions made by the Company during 2025 in accordance with Capital Markets Board regulations, and to determine and approve the upper limit for donations to be made until the date of the next Ordinary General Meeting | ||||||||||||||||||||||
14 - Providing shareholders with information regarding guarantees, pledges, mortgages and sureties granted by the Company in favour of third parties in 2025, as well as any income or benefits derived therefrom, in accordance with the regulations of the Capital Markets Board | ||||||||||||||||||||||
15 - Providing information to the General Meeting in accordance with Principle 1.3.6 of the Corporate Governance Principles | ||||||||||||||||||||||
16 - In relation to the 2025 financial year: Providing shareholders with information regarding transactions conducted with "Related Parties" in accordance with the regulations of the Capital Markets Board | ||||||||||||||||||||||
17 - 17. In accordance with the Capital Markets Board's Corporate Governance Communiqué (II-17.1); to provide shareholders with information regarding the Company's "Remuneration Policy" | ||||||||||||||||||||||
18 - 18. In accordance with the Capital Markets Board's Corporate Governance Regulation (II-17.1); the Company's "Code of Ethical Conduct Policy" to be discussed and submitted to shareholders for approval | ||||||||||||||||||||||
19 - 19. In accordance with the Capital Markets Board's Corporate Governance Regulation (II-17.1); the Company's "Share Buy-back Policy" to be discussed and submitted to shareholders for approval | ||||||||||||||||||||||
20 - 20. Providing shareholders with information regarding the current share buy-back programme | ||||||||||||||||||||||
21 - 21. Comments, good wishes and closing remarks | ||||||||||||||||||||||
Corporate Actions Involved In Agenda | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Additional Explanations | ||||||||||||||||||||||
At the meeting of our Board of Directors held on 7 May 2026; it was resolved that the Ordinary General Meeting of the Company for the 2025 financial year shall be held on 2 June 2026 at 13:30 at the Dedeman Istanbul Hotel, Pınar - 1 Meeting Room, located at Gayrettepe, Yıldız Posta St. No:50, 34340 Beşiktaş/Istanbul, to discuss the agenda items listed above. In case of a discrepancy between the Turkish and English versions of this public disclosure, the Turkish version shall prevail. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.
PDF
WORD
EXCEl